September 1, 2022
Life Sciences
  • The Food and Drug Administration (FDA) authorized two COVID-19 vaccines that were redesigned to target Omicron. This is the first time the FDA has granted updated COVID-19 vaccines emergency use authorization. Pfizer’s updated vaccine is authorized for people age 12 and older while Moderna’s is for people age 18 and older. The boosters could be administered within days to certain populations, pending Centers for Disease Control and Prevention (CDC) approval. (Articles here, here, here, here, here, here, and here)